E
Eric A. Strom
Researcher at University of Texas MD Anderson Cancer Center
Publications - 203
Citations - 11285
Eric A. Strom is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast cancer & Radiation therapy. The author has an hindex of 61, co-authored 199 publications receiving 10497 citations. Previous affiliations of Eric A. Strom include Ohio State University.
Papers
More filters
Journal ArticleDOI
Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks
Marjorie C. Green,Aman U. Buzdar,Terry K. Smith,Nuhad K. Ibrahim,Vicente Valero,Marguerite F. Rosales,Massimo Cristofanilli,Daniel J. Booser,Lajos Pusztai,Edgardo Rivera,Richard L. Theriault,Cynthia Carter,Debra Frye,Kelly K. Hunt,W. Fraser Symmans,Eric A. Strom,Aysegul A. Sahin,William M. Sikov,Gabriel N. Hortobagyi +18 more
TL;DR: The change in schedule of paclitaxel from once every 3 weeks to a more frequent administration significantly improved the ability to eradicate invasive cancer in the breast and lymph nodes.
Journal ArticleDOI
Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation
Angela Katz,Eric A. Strom,Thomas A. Buchholz,Howard D. Thames,Cynthia D. Smith,Anuja Jhingran,Gabriel N. Hortobagyi,Aman U. Buzdar,Richard L. Theriault,Eva Singletary,McNeese D. McNeese +10 more
TL;DR: Patients with tumors >/= 4 cm or at least four involved nodes experience LRR rates in excess of 20% and should be offered adjuvant irradiation and may benefit from postmastectomy irradiation.
Journal ArticleDOI
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
Allen M. Chen,Funda Meric-Bernstam,Kelly K. Hunt,Howard D. Thames,Mary Jane Oswald,Elesyia D. Outlaw,Eric A. Strom,Marsha D. McNeese,Henry Mark Kuerer,Merrick I. Ross,S. Eva Singletary,F. C. Ames,Barry W. Feig,Aysegul A. Sahin,George H. Perkins,Naomi R. Schechter,Gabriel N. Hortobagyi,Thomas A. Buchholz +17 more
TL;DR: Breast conservation therapy after neoadjuvant chemotherapy results in acceptably low rates of LRR and IBTR in appropriately selected patients, even those with T3 or T4 disease.
Journal ArticleDOI
Delayed-immediate breast reconstruction.
Steven J. Kronowitz,Kelly K. Hunt,Henry Mark Kuerer,Gildy Babiera,Marsha D. McNeese,Thomas A. Buchholz,Eric A. Strom,Geoffrey L. Robb +7 more
TL;DR: Delayed-immediate reconstruction is technically feasible and safe in patients with early-stage breast cancer who may require postmastectomy radiation therapy, and patients who require post Mastectomy radiation Therapy can avoid the aesthetic and radiation-delivery problems that can occur after an immediate breast reconstruction.
Journal ArticleDOI
RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation
Beryl McCormick,Kathryn Winter,Clifford A. Hudis,Henry Mark Kuerer,Eileen Rakovitch,Barbara L. Smith,Nour Sneige,Jennifer Moughan,Amit Shah,Isabelle Germain,Alan C. Hartford,Afshin Rashtian,Eleanor M. Walker,Albert Yuen,Eric A. Strom,Jeannette L. Wilcox,Laura A. Vallow,William Small,Anthony T. Pu,Kevin J. Kerlin,Julia White +20 more
TL;DR: In this good-risk subset of patients with DCIS, with a median follow-up of 7 years, the LF rate was low with observation but was decreased significantly with the addition of RT, and overall and disease-free survival were estimated using the Kaplan-Meier method.